questionsmedicales.fr
Thérapeutique
Traitement médicamenteux
Voies d'administration de substances chimiques et des médicaments
Perfusions parentérales
Perfusions veineuses
Perfusions veineuses : Questions médicales fréquentes
Diagnostic
5
Perfusions veineuses
Évaluation clinique
Tests sanguins
Électrolytes
Déshydratation
Choc hypovolémique
Historique médical
Allergies
Symptômes
5
Réaction allergique
Éruption cutanée
Surcharge liquidienne
Hypertension
Prévention
5
Infections
Techniques aseptiques
Complications
Protocoles médicaux
Éducation des patients
Surveillance
Traitements
5
Solutions salines
Glucose
Administration
Matériel stérile
Antibiotiques
Chimiothérapie
Durée de traitement
Perfusion
Perfusion à domicile
Surveillance
Complications
5
Réaction allergique
Antihistaminiques
Surcharge liquidienne
Hypertension
Facteurs de risque
5
Diabète
Immunosuppression
Anticoagulants
Immunosuppresseurs
Statut nutritionnel
Réponse au traitement
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Perfusions veineuses : Questions médicales les plus fréquentes",
"headline": "Perfusions veineuses : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Perfusions veineuses : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-23",
"dateModified": "2026-02-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Perfusions veineuses"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Perfusions parentérales",
"url": "https://questionsmedicales.fr/mesh/D007263",
"about": {
"@type": "MedicalCondition",
"name": "Perfusions parentérales",
"code": {
"@type": "MedicalCode",
"code": "D007263",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E02.319.267.510"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Perfusions veineuses",
"alternateName": "Infusions, Intravenous",
"code": {
"@type": "MedicalCode",
"code": "D007262",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Anjana Patel",
"url": "https://questionsmedicales.fr/author/Anjana%20Patel",
"affiliation": {
"@type": "Organization",
"name": "Georgetown University."
}
},
{
"@type": "Person",
"name": "Nana Guo",
"url": "https://questionsmedicales.fr/author/Nana%20Guo",
"affiliation": {
"@type": "Organization",
"name": "Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: guonanaicu2@163.com."
}
},
{
"@type": "Person",
"name": "Zhongjie Zhang",
"url": "https://questionsmedicales.fr/author/Zhongjie%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: 1083746593@qq.com."
}
},
{
"@type": "Person",
"name": "Lu Chen",
"url": "https://questionsmedicales.fr/author/Lu%20Chen",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: chenlurico@163.com."
}
},
{
"@type": "Person",
"name": "Zhaodi Zhang",
"url": "https://questionsmedicales.fr/author/Zhaodi%20Zhang",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: jody1982@163.com."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Pharmacokinetics of remimazolam after intravenous infusion in anaesthetised children.",
"datePublished": "2023-09-21",
"url": "https://questionsmedicales.fr/article/37739904",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.bja.2023.08.019"
}
},
{
"@type": "ScholarlyArticle",
"name": "In-Home Intravenous Dexmedetomidine Infusion for Treatment of Dystonia: A Pediatric Case Report.",
"datePublished": "2024-09-23",
"url": "https://questionsmedicales.fr/article/39311454",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1213/XAA.0000000000001851"
}
},
{
"@type": "ScholarlyArticle",
"name": "A single-centre study on abnormal antinuclear antibodies in children caused by intravenous infusion of gamma globulin.",
"datePublished": "2024-07-18",
"url": "https://questionsmedicales.fr/article/39091491",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2024.1410661"
}
},
{
"@type": "ScholarlyArticle",
"name": "Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer.",
"datePublished": "2024-09-16",
"url": "https://questionsmedicales.fr/article/39283505",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00520-024-08807-6"
}
},
{
"@type": "ScholarlyArticle",
"name": "Intrapartum continuous subcutaneous insulin infusion vs intravenous insulin infusion among pregnant individuals with type 1 diabetes mellitus: a randomized controlled trial.",
"datePublished": "2023-07-08",
"url": "https://questionsmedicales.fr/article/37429432",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.ajog.2023.07.003"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Thérapeutique",
"item": "https://questionsmedicales.fr/mesh/D013812"
},
{
"@type": "ListItem",
"position": 3,
"name": "Traitement médicamenteux",
"item": "https://questionsmedicales.fr/mesh/D004358"
},
{
"@type": "ListItem",
"position": 4,
"name": "Voies d'administration de substances chimiques et des médicaments",
"item": "https://questionsmedicales.fr/mesh/D004333"
},
{
"@type": "ListItem",
"position": 5,
"name": "Perfusions parentérales",
"item": "https://questionsmedicales.fr/mesh/D007263"
},
{
"@type": "ListItem",
"position": 6,
"name": "Perfusions veineuses",
"item": "https://questionsmedicales.fr/mesh/D007262"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Perfusions veineuses - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Perfusions veineuses",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Perfusions veineuses",
"description": "Comment évaluer la nécessité d'une perfusion veineuse ?\nQuels tests sont utilisés avant une perfusion ?\nQuels signes indiquent une perfusion nécessaire ?\nComment détecter une complication liée à la perfusion ?\nQuel rôle joue l'historique médical dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D007262#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Perfusions veineuses",
"description": "Quels symptômes peuvent nécessiter une perfusion ?\nComment reconnaître une réaction allergique à une perfusion ?\nQuels signes indiquent une phlébite ?\nQuels symptômes peuvent survenir après une perfusion ?\nComment identifier une surcharge liquidienne ?",
"url": "https://questionsmedicales.fr/mesh/D007262#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Perfusions veineuses",
"description": "Comment prévenir les infections liées aux perfusions ?\nQuelles sont les précautions à prendre avant une perfusion ?\nComment éviter les complications de la perfusion ?\nQuels conseils pour les soins à domicile après une perfusion ?\nComment éduquer les patients sur les perfusions ?",
"url": "https://questionsmedicales.fr/mesh/D007262#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Perfusions veineuses",
"description": "Quels types de solutions sont utilisés en perfusion ?\nComment administrer une perfusion correctement ?\nQuels médicaments peuvent être administrés par perfusion ?\nQuelle est la durée typique d'une perfusion ?\nComment gérer une perfusion à domicile ?",
"url": "https://questionsmedicales.fr/mesh/D007262#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Perfusions veineuses",
"description": "Quelles sont les complications possibles des perfusions ?\nComment traiter une réaction allergique à une perfusion ?\nQuels signes indiquent une surcharge liquidienne ?\nComment gérer une phlébite après une perfusion ?\nQuels sont les risques d'infection liés aux perfusions ?",
"url": "https://questionsmedicales.fr/mesh/D007262#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Perfusions veineuses",
"description": "Quels facteurs augmentent le risque d'infection ?\nComment l'âge influence-t-il les risques de perfusion ?\nQuels médicaments augmentent les risques de complications ?\nComment le statut nutritionnel affecte-t-il les perfusions ?\nQuels comportements augmentent les risques de complications ?",
"url": "https://questionsmedicales.fr/mesh/D007262#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer la nécessité d'une perfusion veineuse ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se base sur l'état d'hydratation, les besoins nutritionnels et la pathologie."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés avant une perfusion ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins, d'hydratation et d'électrolytes sont souvent réalisés."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une perfusion nécessaire ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Déshydratation, choc hypovolémique ou besoin de médicaments intraveineux."
}
},
{
"@type": "Question",
"name": "Comment détecter une complication liée à la perfusion ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller les signes d'infection, de phlébite ou de réaction allergique."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique médical dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'historique aide à identifier les allergies, maladies et traitements antérieurs."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent nécessiter une perfusion ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Symptômes de déshydratation, fatigue extrême ou besoin urgent de médicaments."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique à une perfusion ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éruption cutanée, démangeaisons, gonflement ou difficulté respiratoire."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une phlébite ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, chaleur, douleur ou gonflement au site de perfusion."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent survenir après une perfusion ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, légère douleur au site ou sensation de froid dans le bras."
}
},
{
"@type": "Question",
"name": "Comment identifier une surcharge liquidienne ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gonflement des membres, essoufflement ou hypertension artérielle."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections liées aux perfusions ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser des techniques aseptiques et changer régulièrement le matériel."
}
},
{
"@type": "Question",
"name": "Quelles sont les précautions à prendre avant une perfusion ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vérifier les allergies, l'état de santé et l'hygiène du site de perfusion."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications de la perfusion ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller le site, changer les lignes et respecter les protocoles médicaux."
}
},
{
"@type": "Question",
"name": "Quels conseils pour les soins à domicile après une perfusion ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Surveiller le site, maintenir une bonne hygiène et signaler tout changement."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les perfusions ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer sur les risques, les soins et l'importance de la surveillance."
}
},
{
"@type": "Question",
"name": "Quels types de solutions sont utilisés en perfusion ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Solutions salines, glucose, électrolytes ou solutions nutritives."
}
},
{
"@type": "Question",
"name": "Comment administrer une perfusion correctement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utiliser un matériel stérile, choisir le bon site et surveiller le patient."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent être administrés par perfusion ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Antibiotiques, analgésiques, chimiothérapies ou fluides de réhydratation."
}
},
{
"@type": "Question",
"name": "Quelle est la durée typique d'une perfusion ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "La durée varie de quelques minutes à plusieurs heures selon le traitement."
}
},
{
"@type": "Question",
"name": "Comment gérer une perfusion à domicile ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Suivre les instructions médicales, surveiller les signes d'infection et d'efficacité."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des perfusions ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections, phlébites, réactions allergiques ou surcharge liquidienne."
}
},
{
"@type": "Question",
"name": "Comment traiter une réaction allergique à une perfusion ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Arrêter la perfusion, administrer des antihistaminiques et surveiller le patient."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une surcharge liquidienne ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Gonflement, essoufflement ou hypertension artérielle au cours de la perfusion."
}
},
{
"@type": "Question",
"name": "Comment gérer une phlébite après une perfusion ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Appliquer de la chaleur, surveiller et éventuellement administrer des anticoagulants."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'infection liés aux perfusions ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les infections peuvent survenir par contamination du site ou du matériel utilisé."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Diabète, immunosuppression, mauvaise hygiène ou matériel non stérile."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il les risques de perfusion ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées ont un risque accru de complications et d'infections."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent les risques de complications ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants et immunosuppresseurs peuvent accroître les risques."
}
},
{
"@type": "Question",
"name": "Comment le statut nutritionnel affecte-t-il les perfusions ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un statut nutritionnel déficient peut compliquer la réponse aux perfusions."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent les risques de complications ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le tabagisme, l'alcoolisme et le non-respect des soins peuvent aggraver les risques."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 12/02/2026
Contenu vérifié selon les dernières recommandations médicales
2 publications dans cette catégorie
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: guonanaicu2@163.com.
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: 1083746593@qq.com.
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: chenlurico@163.com.
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
Department of Anesthesiology, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: jody1982@163.com.
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, China. Electronic address: changsongwangicu@163.com.
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
The Rotunda Hospital, Dublin, Ireland; Department of Paediatrics, RCSI University of Medicine and Health Sciences, Dublin, Ireland.
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland; The Rotunda Hospital, Dublin, Ireland.
Publications dans "Perfusions veineuses" :
2 publications dans cette catégorie
Affiliations :
School of Pharmacy and Biomolecular Sciences, RCSI University of Medicine and Health Sciences, Dublin, Ireland. Electronic address: fionaobrien@rcsi.ie.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Department of Medicine, Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan. Electronic address: hsabbah1@hfhs.org.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Department of Medicine, Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Department of Medicine, Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Department of Medicine, Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Department of Medicine, Division of Cardiovascular Medicine, Henry Ford Hospital, Detroit, Michigan.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Arena Pharmaceuticals, Inc., San Diego, California.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Arena Pharmaceuticals, Inc., San Diego, California.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Arena Pharmaceuticals, Inc., San Diego, California.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
Arena Pharmaceuticals, Inc., San Diego, California.
Publications dans "Perfusions veineuses" :
1 publication dans cette catégorie
Affiliations :
School of Nursing, Faculty of Health and Wellbeing, Canterbury Christ Church University, Kent, England.
Publications dans "Perfusions veineuses" :
The pharmacokinetic properties of the new benzodiazepine remimazolam have been studied only in adults. We investigated the pharmacokinetics of remimazolam after i.v. infusion in anaesthetised paediatr...
Twenty-four children (2-6 yr, ASA physical status 1-2, BMI 15-18 kg m...
Pharmacokinetics were best described by a three-compartment model for remimazolam and a two-compartment model for CNS7054 linked by a transit compartment. Remimazolam showed a high clearance of 15.9 (...
Remimazolam in children was characterised by a high clearance and short context-sensitive half-time. When normalised to weight, pharmacokinetic properties were similar to those reported for adults....
ChiCTR2200057629....
The off-label use of an intravenous dexmedetomidine infusion is an option for refractory symptoms in pediatric palliative care with a few published cases of in-home use, most limited to end-of-life ca...
To clarify the impact of intravenous infusion of gamma globulin (IVIg) on antinuclear antibodies (ANAs) in children....
A retrospective analysis was performed on the data of children with nonspecific autoantibody-related diseases whose antinuclear antibody (ANA) and autoantibody profiles were detected in our hospital f...
All patients in the IVIg group had either positive ANAs or positive autoantibodies. Anti-SSA, anti-Ro52 and anti-AMA Mi2 were the top three autoantibodies in the IVIg group. The proportions of patient...
It is recommended that if rheumatic diseases are suspected, ANA detection should be carried out beforeIVIg infusion. But for patients who are positive for at least one of these three autoantibodies af...
Oxaliplatin, a major drug in metastatic colorectal cancer (mCRC), is responsible for cumulative, dose-limiting peripheral neuropathy (PN). Whether the hepatic arterial infusion (HAI) route can limit o...
We compared the frequency and severity of PN in oxaliplatin-naive patients with mCRC included in trials that evaluated treatment with oxaliplatin administered either by HAI (ACCORD 04, CHOICE, OSCAR, ...
A total of 363 patients were included (IV, 300; HAI, 63). In total, 180 patients in the IV group (60%) and 30 patients in the HAI group (48%) developed clinically significant PN, with no significant d...
The administration of oxaliplatin HAI rather than IV in the treatment of mCRC does not reduce the incidence, precocity, and severity of PN....
Intrapartum glucose management is critical to reducing neonatal hypoglycemia shortly after birth. Although it is known that insulin is required for all pregnant individuals with type 1 diabetes mellit...
This study aimed to compare the effect of intrapartum use of continuous subcutaneous insulin infusion with that of intravenous insulin infusion for glucose management among pregnant individuals with t...
This was a randomized controlled trial of pregnant participants with type 1 diabetes mellitus. After written informed consent, participants were randomly allocated to 1 of 2 intrapartum insulin admini...
Between March 2021 and April 2023, 76 participants were approached, and 70 participants were randomized (35 participants in the intravenous insulin infusion group and 35 participants in the continuous...
Pregnant individuals with type 1 diabetes mellitus using either intravenous insulin infusion or continuation of their continuous subcutaneous insulin infusion for intrapartum insulin administration ha...
Recent studies have underscored the potential of innovative administration methods to mitigate the capacity burden on healthcare systems, without compromising the quality of care. This study assessed ...
In this micro-costing study, data on resource use and time allocation for drug preparation and administration were collected using an observational, non-interventional study design. Data were register...
Drug administration through the elastomeric pump resulted in substantially lower healthcare costs when compared to conventional infusion, particularly due to reduced labor and chair time. The elastome...
This study demonstrated that the elastomeric pump not only offers substantial cost savings but also enhances the treatment capacity of the oncology day care unit. These findings support the adoption o...
This study has been registered in the National Trial Register (NTR), with the reference number NTR NL9473. Registration date: 05-05-2021....
Iron-deficiency anemia in pregnancy is highly prevalent and presents significant risk to patients. Initial treatment is often with oral medication. We hypothesized that intravenous ferumoxytol would r...
This study aimed to investigate whether 2 infusions of intravenous ferumoxytol are superior to the use of twice-daily oral ferrous sulfate for the treatment of iron-deficiency anemia in pregnancy....
A randomized controlled trial was performed in which participants with anemic (hemoglobin <11 g/dL and hematocrit <33%) were allocated to receive either 2 infusions of 510 mg of intravenous ferumoxyto...
There were 124 participants (N=62 per group). In the intravenous iron group, the mean change in hemoglobin was 1.86 g/dL (95% confidence interval, 1.57 g/dL-2.14 g/dL) and in the oral group was 0.79 g...
Intravenous ferumoxytol was well tolerated, and it was associated with statistically significant increases in maternal hemoglobin, hematocrit, iron, and ferritin compared to oral ferrous sulfate....
Ketamine is an emerging treatment for treatment-resistant depression (TRD) associated with rapid and robust improvements in depressive symptoms and suicidality. However, the efficacy and safety of ket...
In this retrospective analysis, TAY patients (...
A significant main effect of infusions on reduction of total QIDS-SR16 (...
Ketamine was associated with comparable clinical benefits, safety, and tolerability in a TAY sample as compared to a matched GA TRD sample....
Subvisible particles generated during the preparation or administration of biopharmaceuticals might increase the risk of immunogenicity, inflammation, or organ dysfunction. To investigate the impact o...
Acetaminophen (paracetamol) is a ubiquitously administered drug in critically ill patients. Considering the dearth of literature, we evaluated the population pharmacokinetics of intravenous acetaminop...
Critically ill adults receiving intravenous acetaminophen were included in the study. One to three blood samples were withdrawn per patient for the estimation of acetaminophen, and its metabolites (ac...
Eighty-seven participants were recruited. A joint two-compartment acetaminophen pharmacokinetic model linked to glucuronide and sulfate metabolite compartments was used. The central and peripheral vol...
A joint pharmacokinetic model for intravenous acetaminophen and its principal metabolites in a critically ill patient population has been developed. Acetaminophen CL in this patient population is redu...